Pharmaceutical News

RSS

FDA to convene virtual meeting to discuss pediatric use of COVID-19 vaccines

The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research.

10 May 2021

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival. The study is currently available on the bioRxiv* preprint server.

9 May 2021

Complementary medicines for weight loss cannot be justified based on current evidence, review suggests

The first global review of complementary medicines (herbal and dietary supplements) for weight loss in 16 years--combining 121 randomized placebo-controlled trials including nearly 10,000 adults--suggests that their use cannot be justified based on the current evidence.

8 May 2021

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Today, deliveries via cesarean sections, or c-sections, have become quite common globally. Sometimes, c-sections are a medical necessity when normal deliveries become risky either for the mother or the baby.

7 May 2021

Public hearing to be held today for inquiry into approval processes for new drugs, medical technologies

A third day of public hearings in Sydney will be held today as part of the Health, Aged Care and Sport Committee’s ongoing inquiry into approval processes for new drugs and novel medical technologies in Australia.

7 May 2021

Researchers report encouraging results from experimental antiviral targeting Marburg virus

The Marburg virus, a relative of the Ebola virus, causes a serious, often-fatal hemorrhagic fever. Transmitted by the African fruit bat and by direct human-to-human contact, Marburg virus disease currently has no approved vaccine or antivirals to prevent or treat it.

7 May 2021

A new method for producing faster and more efficient vaccines

Vaccines are currently a great source of hope for many people, as it is believed they will help to protect society against COVID-19 and pave the way back to a normal life. The current focus is clearly on coronavirus — but vaccines are also fundamental to combating other pathogens.

7 May 2021

Opioid prescribing behavior can also be decreased by supply shortage, shows study

When evaluating the opioid crisis, research reveals that external factors - such as the volume of pre-filled syringes, or a default number of opioid tablets that could easily be ordered at discharge for the patient - can shift prescribing and compel emergency department (ED) physicians to administer or prescribe greater quantities of opioids.

6 May 2021

New method for qualifying safe drug dosing regimens in pediatrics

Determining safe yet effective drug dosages for children is an ongoing challenge for pharmaceutical companies and medical doctors alike.

6 May 2021

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.

6 May 2021

KHN’s ‘What the Health?’: Sharing vaccines with the world

The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.

6 May 2021

Many adults with hypertension may be taking other medications that could raise blood pressure

Nearly 1 in 5 adults with high blood pressure, a leading risk factor for heart disease and stroke, also take a medicine that could be elevating their blood pressure, according to new research presented at the American College of Cardiology's 70th Annual Scientific Session.

6 May 2021

Personalized medicines could be manufactured with 3D printing technology

Customized medicines could one day be manufactured to patients’ individual needs, with University of East Anglia (UEA) researchers investigating technology to 3D ‘print’ pills.

6 May 2021

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

6 May 2021

Study examines artemisinin-based combination therapy as first-line treatment for malaria

When a mosquito begins to nibble on you, it is not merely feeding on your blood, it is also injecting its saliva into your skin. If that saliva happens to be full of parasites carrying malaria or other diseases from its last victim, then most likely you will become infected, too.

6 May 2021

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

WHO Dr Tedros Adhanom Ghebreyesus welcomed the Government of Sweden's announcement today to share 1 million doses of the AstraZeneca vaccine with the COVAX Facility to provide life-saving vaccines to people at risk from COVID-19 in low income countries.

6 May 2021

World Health Organization lists Moderna COVID-19 vaccine for emergency use

Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO.

6 May 2021

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.

6 May 2021

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders.

5 May 2021

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

5 May 2021

Pharmaceutical News

FDA to convene virtual meeting to discuss pediatric use of COVID-19 vaccines

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Complementary medicines for weight loss cannot be justified based on current evidence, review suggests

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Public hearing to be held today for inquiry into approval processes for new drugs, medical technologies

Researchers report encouraging results from experimental antiviral targeting Marburg virus

A new method for producing faster and more efficient vaccines

Opioid prescribing behavior can also be decreased by supply shortage, shows study

New method for qualifying safe drug dosing regimens in pediatrics

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

KHN’s ‘What the Health?’: Sharing vaccines with the world

Many adults with hypertension may be taking other medications that could raise blood pressure

Personalized medicines could be manufactured with 3D printing technology

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

Study examines artemisinin-based combination therapy as first-line treatment for malaria

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

World Health Organization lists Moderna COVID-19 vaccine for emergency use

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News